Gastric Cancer in the Young: Is It a Different Clinical Entity? A Retrospective Cohort Study

Table 3

Surgical treatment, length of postoperative hospital stay, and chemotherapy.

Parameter	<50 years; (20)	≥50 years; (112)	𝑃
Gastric resection
Total gastrectomy by necessity	7 (35.0%)	39 (34.8%)	0.513
Total gastrectomy as scheduled procedure	3 (15.0%)	7 (6.3%)	0.359
Subtotal gastrectomy as scheduled procedure	10 (50.0%)	66 (58.9%)	0.618
Lymphadenectomy
<D2	3 (15.0%)	11 (9.8%)	0.765
≥D2	17 (85.0%)	101 (90.2%)
Combined resection
Distal esophagectomy	—	6 (5.3%)	0.682
Distal pancreatectomy	—	1 (0.9%)
Cholecystectomy	7 (35.0%)	35 (31.2%)
Appendectomy	—	1 (0.9%)
Splenectomy	—	1 (0.9%)
Liver resection for angioma	—	2 (1.8%)
Left adrenalectomy for adenoma	—	1 (0.9%)
Postoperative hospital stay (days) ± SD
Overall	19.5±6.8	18.7±8.2	0.606
Range	10–32	10–38
Median	17	17	0.435
Total gastrectomy	20.1±4.2	19.2±6.1
Median	19	18	0.734
Subtotal gastrectomy	17.4±5.0	18.0±8.2
Median	17	16
Chemotherapy
Yes	5 (25.0%)	24 (21.4%)
No	15 (75.0%)	88 (78.6%)	0.950
Neoadjuvant	1 (5.0%)	—	0.329
Adjuvant	4 (20.0%)	24 (21.4%)	0.878

SD: standard deviation; 𝑃 values are bilateral.